M. Arning

8.5k citations
53 papers · 6.8k · 5 hit papers · h-index 27

Impact in

  • Hematology top 0.5%
    • Platelet Disorders and Treatments
    • Blood groups and transfusion
  • Oncology top 1%
    • Pancreatic and Hepatic Oncology Research
    • Cancer Immunotherapy and Biomarkers

Papers in

    • Platelet Disorders and Treatments 7
    • Blood groups and transfusion 4
    • Neutropenia and Cancer Infections 8
    • Pancreatic and Hepatic Oncology Research 6
    • Cancer Treatment and Pharmacology 4

M. Arning

50 papers receiving 6.6k citations

M. Arning's Hit Papers

Adjuvant Chemotherapy With Gemcitabine and Long-term Outcomes Among Patients With Resected Pancreatic Cancer 2013 · 1.4k citations
1.4k0+7+14Years since publication4008001.2k

Peers

M. Arning
Comparison fields: 5 of 101
  • Hematology 2.0k
  • Oncology 2.4k
  • Surgery 2.0k
  • Genetics 470
  • Cancer Research 533
Replace Thomas Kühne with:
Thomas Kühne Switzerland
David Allan Cairns United Kingdom
Jacques‐Olivier Bay France
Shin Mineishi United States
Johannes Thaler Austria
Jeffrey A. Zonder United States
Vincent J. Picozzi United States
Semra Paydaş Türkiye
Ullrich Graeven Germany
David H. Irwin United States
M. Arning relative to Thomas Kühne Switzerland Thomas Kühne's profile →
Citations per field
00.5×2×2.7×
Thomas Kühne · 1×
Citations per year

Countries citing papers authored by M. Arning

Since Specialization
Citations

This map shows the geographic impact of M. Arning's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Arning with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Arning more than expected).

Fields of papers citing papers by M. Arning

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Arning. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Arning. The network helps show where M. Arning may publish in the future.

Co-authors

The 25 scholars most cited alongside M. Arning, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with M. Arning Line = papers co-authored together M. Arning links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 53 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Long-Term Survival Results of a Randomized Trial Comparing Gemcitabine Plus Cisplatin, With Methotrexate, Vinblastine, Doxorubicin, Plus Cisplatin in Patients With Bladder Cancer
Hit paper breakdown →
20051495
2
Adjuvant Chemotherapy With Gemcitabine and Long-term Outcomes Among Patients With Resected Pancreatic Cancer
Hit paper breakdown →
20131437
3
Eltrombopag for the Treatment of Chronic Idiopathic Thrombocytopenic Purpura
Hit paper breakdown →
2007658
4
Eltrombopag for management of chronic immune thrombocytopenia (RAISE): a 6-month, randomised, phase 3 study
Hit paper breakdown →
2010481
5
Effect of eltrombopag on platelet counts and bleeding during treatment of chronic idiopathic thrombocytopenic purpura: a randomised, double-blind, placebo-controlled trial
Hit paper breakdown →
2009450
6 2012284
7 2005269
8 2006208
9 2000154
10 1999141
11 1999133
12 2006125
13 1999115
14 199597
15 200279
16 199969
17 201253
18 200046
19 200640
20 199138

About M. Arning

M. Arning is a scholar working on Hematology, Oncology, Genetics, Epidemiology and Infectious Diseases, having authored 53 papers that have together received 6.8k indexed citations. Recurring topics across this work include Neutropenia and Cancer Infections (8 papers), Platelet Disorders and Treatments (7 papers), Antifungal resistance and susceptibility (7 papers), Pancreatic and Hepatic Oncology Research (6 papers), Chronic Lymphocytic Leukemia Research (6 papers), Fungal Infections and Studies (4 papers), Blood groups and transfusion (4 papers) and Cancer Treatment and Pharmacology (4 papers). The work is most often cited by research in Hematology (2.0k citations), Oncology (2.4k citations), Surgery (2.0k citations), Genetics (470 citations) and Cancer Research (533 citations). M. Arning has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include James Bruce Bussel, Annamaria Hayden Zimmermann, Gregory Yin-Ming Cheng, James T. Roberts, Luigi Dogliotti, T. Oliver, Hans von der Maase, Malcolm J. Moore, Lisa Sengeløv and Sergio Ricci. Their work appears in journals such as Blood, Annals of Hematology, Annals of Oncology, The Lancet and Anti-Cancer Drugs.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact